borderline significanceP =.05
There were no statistically significant differences between low COX-2 immunostaining and high COX-2 immunostaining for most of the clinicopathological parameters with the exception of tumor multifocality where high COX-2 immunostaining showed borderline significance with more cases where multifocality was present ( P =.05) ( Table 4 ).